Skip to main content
. 2021 May 12;13(10):2328. doi: 10.3390/cancers13102328
AB Antibody
AR Androgen receptor
CAFs Cancer associated fibroblasts
CI Confidence interval
ECM Extracellular matrix
ER Estrogen receptor
FOXA1 Forkhead box protein A1
HR Hazard ratio
IHC Immunohistochemistry
NK Natural killer
OS Overall survival
PR Progesterone receptor
ROI Region of interest
RFS Relapse-free survival
TIL Tumor-infiltrating lymphocytes
TMA Tissue microarray
TME Tumor microenvironment
TNBC Triple-negative breast cancer